Company Filing History:
Years Active: 2006-2010
Title: Gary Kalantarov: Innovator in Cancer Detection and Treatment
Introduction
Gary Kalantarov is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer cells. With a total of 2 patents, his work focuses on innovative methods for diagnosing and treating cancer.
Latest Patents
Kalantarov's latest patents revolve around tumor-associated markers. His inventions include monoclonal antibody-producing hybridomas designated 27.F7 and 27.B1. These patents provide methods for detecting TIP-2 antigen-bearing cancer cells in a sample. They also outline techniques for diagnosing cancer in a subject and monitoring the progression of cancer. Furthermore, his inventions include methods for delivering exogenous material to TIP-2 antigen-bearing cancer cells and treating cancer in human subjects. The patents also describe isolated peptides with specific amino acid sequences, which are crucial for the detection and treatment of cancer.
Career Highlights
Kalantarov is affiliated with Columbia University, where he continues to advance his research in cancer detection and treatment. His work has garnered attention for its potential impact on improving cancer diagnostics and therapies.
Collaborations
Some of his notable coworkers include Ilya Trakht and Robert E Canfield, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Gary Kalantarov's innovative work in cancer detection and treatment showcases his commitment to advancing medical science. His patents reflect a significant step forward in the fight against cancer, offering new methods for diagnosis and therapy.